The
coagulation testing market is poised
to grow by USD 991.28 million during 2020-2024, progressing at a CAGR of almost
7% during the forecast period.
Technavio suggests three forecast scenarios (optimistic, probable, and
pessimistic) considering the impact of COVID-19. Download Free Sample
Report on COVID-19 Recovery Analysis
The report on the coagulation testing market provides a holistic update,
market size and forecast, trends, growth drivers, and challenges, as well as
vendor analysis.
The report offers an up-to-date analysis regarding the current global
market scenario, the latest trends and drivers, and the overall market
environment. The market is driven by the high use of POCT devices in developed
countries.
The coagulation testing market analysis includes technology segment and
geography landscape. This study identifies the increasing prevalence of
coagulation disorders driving the demand for coagulation testing devices as one
of the prime reasons driving the coagulation testing market growth during the
next few years.
This report presents a detailed picture of the market by the way of
study, synthesis, and summation of data from multiple sources by an analysis of
key parameters.
The coagulation testing market covers the following areas:
Coagulation Testing Market Sizing
Coagulation Testing Market Forecast
Coagulation Testing Market Analysis
Companies Mentioned
- Abbott Laboratories
- Danaher Corp.
- F. Hoffmann-La Roche Ltd.
- HORIBA Ltd.
- Medtronic Plc
- Nihon Kohden Corp.
- Sekisui Chemical Co. Ltd.
- Siemens Healthineers AG
- Sysmex Corp.
- Thermo Fisher Scientific
Inc.
No comments:
Post a Comment